MedScribe captures one verified clinical fact and intelligently propagates it across consultation notes, informed consent, procedure records, aftercare and compliance audit trails — before the clinician leaves the room.
Documentation Ready
Consultation · Consent · Procedure · Aftercare
<1min
Generated
£3.2bn
UK aesthetics market (2024)
30–60 min
Documentation per clinician / day
5,589
UK private aesthetic clinics
High accuracy
Confidence-guided field verification
The Problem
Clinicians spend 30–60 minutes every day writing consultation notes, consent forms, procedure records, aftercare instructions and audit trails — often outside patient hours. Existing tools solve only fragments of this workflow.
Clinics juggle multiple disconnected platforms for scheduling, notes, consent and treatment records — the same information is re-entered repeatedly.
Generic AI scribes infer product, dosage and consent status from conversation — a medico-legal risk in a regulated aesthetic setting.
General-purpose tools lack aesthetic products, anatomical terminology, dosage standards and consent requirements — increasing hallucination risk.
How it works
MedScribe is a workflow-first AI platform. Clinical information is captured once and intelligently propagated across every downstream document — with confidence-guided clinician verification at every step.
Clinician records the consultation — diagnosis, treatment plan, product, dosage, treatment area and clinical observations.
AI analyses the captured information and populates consultation notes, consent forms, procedure records, aftercare and compliance documents.
Each field is assigned a confidence score. Only low-confidence or missing entries are surfaced for clinician verification.
A complete documentation package is generated in seconds, ready for e-signature, secure storage and future auditing.
Core Innovation Pillars
MedScribe combines full-chain workflow automation, structured safety-critical capture, specialty-tuned speech processing, schema-constrained extraction, deterministic orchestration, template-grounded generation, confidence-guided verification and integrated compliance analytics into a single operating system.
Pillar 01
One verified clinical fact automatically generates consultation notes, informed consent, procedure records, aftercare instructions, follow-up schedules and compliance records as a single connected workflow.
Pillar 02
High-risk variables — product selection, dosage, treatment area and consent confirmation — are captured through clinician-verified inputs rather than inferred from speech.
Pillar 03
Speech recognition trained on cosmetic products, facial anatomy, procedure names, medical abbreviations, multiple accents and clinic background noise, with clinician-patient speaker separation.
Pillar 04
Extracted values are validated against clinical templates, approved treatment protocols, product libraries, dosage ranges and mandatory documentation rules — reducing AI hallucination and enforcing data quality.
Pillar 05
The platform sequences consultation, consent, procedure, aftercare, follow-up and audit recording according to clinic protocol, with automated reminders and task progression.
Pillar 06
Instead of unrestricted generative AI, documents are generated from validated clinical templates populated with verified structured information — producing standardised, regulatory-ready records.
Pillar 07
Every field receives an AI confidence score. High-confidence entries are accepted automatically; low-confidence entries are surfaced for review. Corrections feed back to continuously improve model performance.
Pillar 08
Tamper-evident audit trails, version-controlled records, role-based permissions, encrypted storage, documentation history, compliance reporting, workflow analytics and productivity dashboards support governance and operational insight.
Competitive Differentiation
Most AI scribes generate a consultation note and stop. MedScribe automates the entire connected documentation chain — every verified clinical fact is captured once and intelligently reused across the patient's treatment journey.
Market
The UK medical aesthetics market is valued at ~£3.2 billion and growing ~8.4% annually. Approximately 5,589 clinics and 19,701 practitioners operate across the UK — a highly fragmented base ideally suited to a specialty SaaS platform.
B2B subscription. UK-first, with international expansion into English-speaking and regulated healthcare markets.
£3.2bn
UK aesthetics market
~8.4%
Annual market growth
5,589
Aesthetic clinics
19,701
Qualified practitioners
Three-Year Roadmap
MedScribe is funded by £50,000 of founder equity (£25,000 from each co-founder) and requires no external funding across the three-year plan. Cash remains positive every month.
Year 1
40
Active clinics
£149 / mo
Avg subscription
£38,439
Annual revenue
85.5%
Gross margin
Launch with 10 pilot clinics in London. Validate workflow automation in live clinical environments. First paid subscriptions from Month 7.
Year 2
121
Active clinics
£216 / mo
Avg subscription
£312,172
Annual revenue
86.5%
Gross margin
Repeatable sales and onboarding across London and the wider UK. Recruit initial technical and customer-facing team. Net profit £29,886.
Year 3
207
Active clinics
£262 / mo
Avg subscription
£650,954
Annual revenue
87.0%
Gross margin
Enterprise partnerships, product innovation and export foundations. Headcount reaches 10, creating 8 skilled UK jobs. Net profit £81,081.
Founders
Chief Executive Officer
Medical doctor and aesthetic physician. Conceived MedScribe's workflow-first approach from direct clinical experience, and leads product design, clinical workflows, strategic direction and commercial growth.
Chief Clinical Officer
Co-founder contributing clinical, technical and business expertise to the platform's development, technology decisions and go-to-market strategy across the UK private aesthetics sector.
London Pilot · Months 1–6
We are onboarding early-adopter aesthetic clinics for real-world validation of the platform. Pilot clinics help refine workflows, benefit from priority onboarding and lock in launch pricing.
Request Pilot Access